Key Details
Price
$13.25Last Dividend
$0.12Annual ROE
0.26%Beta
0.52Events Calendar
Next earnings date:
Feb 28, 2025Recent quarterly earnings:
Nov 07, 2024Recent annual earnings:
Feb 28, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Nov 22, 2024Next split:
N/ARecent split:
Oct 09, 2003Analyst ratings
Recent major analysts updates
Screeners with VTRS included
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
On Friday, Britain's competition regulator imposed a fine of 1.5 million pounds ($1.88 million) on the U.S. company Viatris. This penalty was for breaking a rule while they were looking into Theramex's purchase of the European rights to two of Viatris's women's healthcare products.
Viatris Inc. (NASDAQ:VTRS) held a conference call at the Jefferies London Healthcare Conference on November 21, 2024, at 5:30 AM ET. The company was represented by several key executives, including Scott Smith, the CEO, and Doretta Mistras, the CFO. Glen Santangelo from Jefferies also participated in the call, greeting everyone with a good morning.
Viatris Inc. (NASDAQ:VTRS) will be participating in the UBS Global Healthcare Conference on November 12, 2024, at 11:45 AM ET. The company's Chief Financial Officer, Doretta Mistras, will be present, along with Ashwani Verma from UBS, who specializes in small to mid-cap biotech and specialty pharmaceuticals. Welcome to everyone attending the conference.
Viatris has announced impressive earnings results for the third quarter at a bargain price.
Viatris Inc. (NASDAQ:VTRS) will hold its Q3 2024 Earnings Conference Call on November 6, 2024, at 8:30 AM ET. The call will feature company leaders including CEO Scott Smith and CFO Doretta Mistras, along with analysts from various financial institutions. Participants will be in listen-only mode during the call.
VTRS's earnings and sales for the third quarter exceeded expectations. Their new products are doing very well.
In addition to Wall Street's predictions for Viatris' (VTRS) earnings, take a look at forecasts for some important metrics to better understand how the company performed in the quarter that ended in September 2024.
PITTSBURGH, Oct. 29, 2024 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a worldwide healthcare firm, has announced its participation in two upcoming healthcare conferences. More information about the presentations is provided below: UBS Global Healthcare Conference Date: Tuesday, November 12, 2024 Time: 8:45 a.m.
PITTSBURGH, Oct. 29, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a worldwide healthcare firm, has been recognized on Forbes' 2024 list of the World's Top Companies for Women. This honor is given in partnership with Statista, a leading provider of statistics and industry rankings.
Lexicon will get an initial payment of $25 million, along with the possibility of additional payments based on regulatory and commercial achievements.
FAQ
- What is the primary business of Viatris?
- What is the ticker symbol for Viatris?
- Does Viatris pay dividends?
- What sector is Viatris in?
- What industry is Viatris in?
- What country is Viatris based in?
- When did Viatris go public?
- Is Viatris in the S&P 500?
- Is Viatris in the NASDAQ 100?
- Is Viatris in the Dow Jones?
- When was Viatris's last earnings report?
- When does Viatris report earnings?
- Should I buy Viatris stock now?